Clinical chemistry is the area of clinical pathology which deals with the analysis of body fluids for the therapeutic and diagnostic purposes. It is an applied form of biochemistry. The most common tests, such as metabolic tests, which are prescribed by physicians for the diagnosis of diseases, dominated the US clinical chemistry testing market.
The US market for such clinical chemistry tests was valued at approximately US$ 36.3 Billion in 2016. The major players operating in the clinical chemistry analyzers market include Roche Diagnostics, Danaher Corporation, Abbott Diagnostics, Siemens AG, Ortho-Clinical Diagnostics, Thermo Fisher Scientific, Randox Laboratories Ltd., ElitechGroup and Mindrayand, among others.
Furthermore, the growing aging population will lead to rise in number of screening and diagnostic test propelling the industry growth. Moreover, the growth of the US clinical laboratory testing market is also likely to be driven by increasing prevalence of diseases like cardiovascular, diabetes, liver & kidney disorders, and blood disorders. The growing number of cases of drug abuse will also compel authorities to conduct more of these tests. In addition, other factors such as active private sector participation and rising awareness level will also drive the growth of this market in the coming years.